Artificial intelligence software company Viz.ai is partnering with health care company Sanofi and biotechnology company Regeneron to develop an AI-powered workflow solution for COPD.
According to a news release, the companies will investigate the use of the Viz COPD module, a care acceleration solution that leverages electronic health record (EHR) data and artificial intelligence (AI) to advance detection and management of high-risk COPD patients.
The Viz COPD module will evaluate EHR data using natural language processing to screen and triage patients in line with established clinical guidelines, flagging high-risk individuals for further follow-up and care.
The module builds on Viz.ai’s existing presence in more than 1,700 hospitals and health systems. Paul Rowe, MD, head of medical and specialty care at Sanofi, said he is hopeful that the project will lead to more streamlined care and better outcomes for COPD patients.
“With this collaboration, we will study the impact of the Viz COPD module, a streamlined, AI-enabled EHR workflow, to improve access to care and ultimately patient outcomes in COPD,” Dr. Rowe said.
Chris Mansi, MD, CEO and co-founder of Viz.ai, said that the collaboration is “a major step forward” in the company’s mission to expand AI-driven care to areas with critical, unmet needs.
“Our approach aims to empower health care providers to deliver data-driven, guideline-directed care that meaningfully impacts patient outcomes,” Dr. Mansi said.
